Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients—Why Do It?

Overview of attention for article published in Journal of Clinical Oncology, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 3 news stories from 2 outlets.

Bradley Monk, MD, on Use of Rucaparib in Newly Diagnosed Ovarian Cancer

MedPage Today, 22 Jun 2022

This Reading Room is a collaboration between MedPage Today® and: Monotherapy with the PARP inhibitor rucaparib is an effective…

Mammakarzinom und kardiale Erkrankungen; Zervixkarzinom und HPV-Infektion

Medscape, 12 Apr 2022

Im Onko-Blog dieser Woche geht es unter anderem um 2 Phase-3-Studien mit Immuncheckpoint-Inhibitoren, die jeweils zu einer…

Study Confirms Favorable Prognosis for HPV-Positive Cervical Cancer

MedPage Today, 06 Apr 2022

Oncology/Hematology > Cervical Cancer RNA sequencing identified more HPV+ tumors, showed 43% mortality disparity for HPV…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.